This study is currently not recruiting participants.

PHASE 2 STUDY OF ADXS11-001 IN SUBJECTS WITH PERSISTENT/RECURRENT LOCO-REGIONAL OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE ANORECTAL CANAL

  • STATUS
    Not Recruiting
Send
Updated on 19 February 2024

Summary

This is a 2-stage study. Stage 1 and 2 of the study are monotherapy evaluations of ADXS11-001 in 31 and 24 subjects, respectively with persistent/recurrent, loco-regional or metastatic anal cancer or HPV+ squamous cell carcinoma of the rectum that are either treatment na?ve in the metastatic setting or have progressed or become intolerant to platinum based therapy.

Description

This is a 2-stage study. Stage 1 and 2 of the study are monotherapy evaluations of ADXS11-001 in 31 and 24 subjects, respectively with persistent/recurrent, loco-regional or metastatic anal cancer or HPV+ squamous cell carcinoma of the rectum that are either treatment na?ve in the metastatic setting or have progressed or become intolerant to platinum based therapy.

Details
Condition anal cancer,rectal cancer
Age 18years - 100years
Clinical Study IdentifierTX6968
Last Modified on19 February 2024

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.